Literature DB >> 9841529

Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning.

M Osada1, T Netticadan, K Tamura, N S Dhalla.   

Abstract

To examine the effects of ischemic preconditioning on ischemia-reperfusion-induced changes in the sarcoplasmic reticulum (SR) function, isolated rat hearts were either perfused with a control medium for 30 min or preconditioned with three episodes of 5-min ischemia and 5-min reperfusion before sustained ischemia for 30 min followed by reperfusion for 30 min was induced. Preconditioning itself depressed cardiac function (left ventricular developed pressure, peak rate of contraction, and peak rate of relaxation) and SR Ca2+-release and -uptake activities as well as protein content and Ca2+/calmodulin-dependent protein kinase (CaMK) phosphorylation of Ca2+-release channels by 25-60%. Global ischemia for 30 min produced marked depressions in SR Ca2+-release and -uptake activities as well as SR Ca2+-pump protein content in control hearts; these changes were significantly attenuated by preconditioning. Compared with the control preparations, preconditioning improved the recovery of cardiac function and SR Ca2+-release and -uptake activities as well as Ca2+-release channel and Ca2+-pump protein contents in the ischemic-reperfused hearts. Unlike the protein kinase A-mediated phosphorylation in SR membranes, the CaMK-mediated phosphorylations at Ca2+-release channels, Ca2+ pump, and phospholamban were depressed in the ischemic hearts; these changes were prevented by preconditioning. These results indicate that ischemic preconditioning may exert beneficial effects on ischemia-reperfusion-induced alterations in SR function by preventing changes in Ca2+-release channel and Ca2+-pump protein contents in the SR membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841529     DOI: 10.1152/ajpheart.1998.274.6.H2025

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats.

Authors:  Qiufang Zhang; Jizhou Xiang; Xuanbin Wang; Hui Liu; Benrong Hu; Mei Feng; Qin Fu
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Phosphorylation of phospholamban in ischemia-reperfusion injury: Functional role of Thr(17) residue.

Authors:  A Mattiazzi; C Mundiña-Weilenmann; L Vittone; M Said
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

3.  Discrepancy in calcium release from the sarcoplasmic reticulum and intracellular acidic stores for the protection of the heart against ischemia/reperfusion injury.

Authors:  Aseel Khalaf; Fawzi Babiker
Journal:  J Physiol Biochem       Date:  2016-06-21       Impact factor: 4.158

4.  Comparing cardioprotetion by DiOHF intervention and ischemic preconditioning.

Authors:  Yeong-Renn Chen
Journal:  Int J Cardiol       Date:  2018-05-15       Impact factor: 4.164

5.  Influence of extracellular potassium on the antiarrhythmic effect of global preconditioning in isolated perfused rat hearts.

Authors:  J Feng; R Chahine; R Nadeau
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

6.  Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil.

Authors:  S Takeo; A B Elmoselhi; R Goel; E Sentex; J Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-10       Impact factor: 3.396

7.  Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge.

Authors:  Cecilia Mundiña-Weilenmann; Matilde Said; Leticia Vittone; Paola Ferrero; Alicia Mattiazzi
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

8.  Attenuation of ischemia-reperfusion induced changes in cardiac performance and sarcoplasmic reticulum function by vanadate.

Authors:  Satoshi Takeda; Dashang Prajapati; Seibu Mochizuki; Vijayan Elimban; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2003

9.  Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart.

Authors:  Zainisha Vasanji; Naranjan S Dhalla; Thomas Netticadan
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

10.  Protein kinase C modulation of the regulation of sarcoplasmic reticular function by protein kinase A-mediated phospholamban phosphorylation in diabetic rats.

Authors:  Satoko Watanuki; Naoyuki Matsuda; Fumika Sakuraya; Subrina Jesmin; Yuichi Hattori
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.